"10.1371_journal.pone.0119509","plos one","2015-03-20T00:00:00Z","Stacie L Lambert; Shahin Aslam; Elizabeth Stillman; Mia MacPhail; Christine Nelson; Bodrey Ro; Rosemary Sweetwood; Yuk Man Lei; Jennifer C Woo; Roderick S Tang","Department of Research, MedImmune, Mountain View, California, United States of America","Conceived and designed the experiments: SLL JCW ES RST. Performed the experiments: SLL SA ES CN MM YML BR RS. Analyzed the data: SLL SA ES CN MM YML BR RS. Wrote the paper: SLL SA ES RST JCW.","At the time this work was generated, all authors were employed by MedImmune, whose company funded this study and which has an RSV sF + GLA-SE vaccine product in development. All authors also had stock or stock options in AstraZeneca, the parent company of MedImmune. JCW has been employed by Immune Design, which developed the GLA-SE adjuvant. SL, ES, JCW, and RST are coauthors on a pending MedImmune patent application number PCT/US 2014/032938 entitled “Vaccine Composition and Method of Use.” RST is also a coauthor on patent application number WO 2012/103496 entitled “Expression of soluble viral fusion glycoproteins in mammalian cells”. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Stacie L Lambert","SLL",10,TRUE,4,8,8,5,TRUE,TRUE,FALSE,0,NA,FALSE
